{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:49Z","timestamp":1792806049063,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014 SGR-984"],"award-info":[{"award-number":["2014 SGR-984"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["PRE2022-101261"],"award-info":[{"award-number":["PRE2022-101261"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"name":"American Parkinson\u2019s Foundation","award":["APDA Summer Student Fellowship 2020"],"award-info":[{"award-number":["APDA Summer Student Fellowship 2020"]}],"id":[{"id":"https:\/\/ror.org\/05mx85j86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"American Parkinson\u2019s Foundation","award":["APDA Summer Student Fellowship 2019"],"award-info":[{"award-number":["APDA Summer Student Fellowship 2019"]}],"id":[{"id":"https:\/\/ror.org\/05mx85j86","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01249-9","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:23:03Z","timestamp":1768540983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Microglial low-affinity Fc\u03b3R mediates the phagocytic elimination of dopaminergic neurons in Parkinson\u2019s disease degeneration"],"prefix":"10.1038","volume":"12","author":[{"given":"P. V.","family":"Casanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Freitag-Berenguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Saavedra-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Usandizaga-Estarloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"R\u00edos-Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mart\u00ednez-Remedios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gim\u00e9nez-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Clinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roig-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. P.","family":"Cribaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Barcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"1249_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tins.2023.07.005","volume":"46","author":"J Lauritsen","year":"2023","unstructured":"Lauritsen, J. & Romero-Ramos, M. The systemic immune response in Parkinson\u2019s disease: focus on the peripheral immune component. Trends Neurosci. 46, 863\u2013878 (2023).","journal-title":"Trends Neurosci."},{"key":"1249_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1249_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/mds.28075","volume":"36","author":"EC Hirsch","year":"2021","unstructured":"Hirsch, E. C. & Standaert, D. G. Ten unsolved questions about neuroinflammation in Parkinson\u2019s Disease. Mov. Disord. 36, 16\u201324 (2021).","journal-title":"Mov. Disord."},{"key":"1249_CR4","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer, P. L., Itagaki, S., Boyes, B. E. & McGeer, E. G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38, 1285\u20131291 (1988).","journal-title":"Neurology"},{"key":"1249_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura, K. et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol. 106, 518\u2013526 (2003).","journal-title":"Acta Neuropathol."},{"key":"1249_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston, J. W. et al. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 46, 598\u2013605 (1999).","journal-title":"Ann. Neurol."},{"key":"1249_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ana.10728","volume":"54","author":"PL McGeer","year":"2003","unstructured":"McGeer, P. L., Schwab, C., Parent, A. & Doudet, D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann. Neurol. 54, 599\u2013604 (2003).","journal-title":"Ann. Neurol."},{"key":"1249_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/glia.20015","volume":"46","author":"C Barcia","year":"2004","unstructured":"Barcia, C. et al. Evidence of active microglia in substantia nigra pars compacta of Parkinsonian monkeys 1 year after MPTP exposure. Glia 46, 402\u2013409 (2004).","journal-title":"Glia"},{"key":"1249_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.55782\/ane-1999-1289","volume":"59","author":"I Kurkowska-Jastrzebska","year":"1999","unstructured":"Kurkowska-Jastrzebska, I., Wronska, A., Kohutnicka, M., Czlonkowski, A. & Czlonkowska, A. MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson\u2019s disease. Acta Neurobiol. Exp. 59, 1\u20138 (1999).","journal-title":"Acta Neurobiol. Exp."},{"key":"1249_CR10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","volume":"1","author":"PL McGeer","year":"2004","unstructured":"McGeer, P. L. & McGeer, E. G. Inflammation and neurodegeneration in Parkinson\u2019s disease. Park. Relat. Disord. 1, S3\u2013S7 (2004).","journal-title":"Park. Relat. Disord."},{"key":"1249_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.17","volume":"2","author":"C Barcia","year":"2011","unstructured":"Barcia, C. et al. IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease. Cell Death Dis. 2, e142 (2011).","journal-title":"Cell Death Dis."},{"key":"1249_CR12","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","volume":"27","author":"MP Mount","year":"2007","unstructured":"Mount, M. P. et al. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J. Neurosci. 27, 3328\u20133337 (2007).","journal-title":"J. Neurosci."},{"key":"1249_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","volume":"414","author":"M Mogi","year":"2007","unstructured":"Mogi, M., Kondo, T., Mizuno, Y. & Nagatsu, T. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neurosci. Lett. 414, 94\u201397 (2007).","journal-title":"Neurosci. Lett."},{"key":"1249_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","volume":"10","author":"VH Perry","year":"2014","unstructured":"Perry, V. H. & Holmes, C. Microglial priming in neurodegenerative disease. Nat. Rev. Neurol. 10, 217\u2013224 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"1249_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep00809","volume":"2","author":"C Barcia","year":"2012","unstructured":"Barcia, C. et al. ROCK\/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo. Sci. Rep. 2, 809 (2012).","journal-title":"Sci. Rep."},{"key":"1249_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41577-023-00921-6","volume":"24","author":"GC Brown","year":"2024","unstructured":"Brown, G. C. Cell death by phagocytosis. Nat. Rev. Immunol. 24, 91\u2013102 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1249_CR17","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1093\/brain\/awh625","volume":"128","author":"CF Orr","year":"2005","unstructured":"Orr, C. F., Rowe, D. B., Mizuno, Y., Mori, H. & Halliday, G. M. A possible role for humoral immunity in the pathogenesis of Parkinson\u2019s disease. Brain 128, 2665\u20132674 (2005).","journal-title":"Brain"},{"key":"1249_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1006\/exnr.2002.7946","volume":"176","author":"Y He","year":"2002","unstructured":"He, Y., Le, W. D. & Appel, S. H. Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra. Exp. Neurol. 176, 322\u2013327 (2002).","journal-title":"Exp. Neurol."},{"key":"1249_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-5-42","volume":"5","author":"S Cao","year":"2010","unstructured":"Cao, S., Theodore, S. & Standaert, D. G. Fcgamma receptors are required for NF-kappaB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson\u2019s disease. Mol. Neurodegener. 5, 42 (2010).","journal-title":"Mol. Neurodegener."},{"key":"1249_CR20","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1091\/mbc.e09-03-0230","volume":"20","author":"H Park","year":"2009","unstructured":"Park, H. & Cox, D. Cdc42 regulates Fc gamma receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich syndrome protein (WASP) and neural-WASP. Mol. Biol. Cell 20, 4500\u20134508 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"1249_CR21","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.1093\/emboj\/17.21.6219","volume":"17","author":"P Massol","year":"1998","unstructured":"Massol, P., Montcourrier, P., Guillemot, J. C. & Chavrier, P. Fc receptor-mediated phagocytosis requires CDC42 and Rac1. EMBO J. 17, 6219\u20136229 (1998).","journal-title":"EMBO J."},{"key":"1249_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jlb.66.5.712","volume":"66","author":"S Greenberg","year":"1999","unstructured":"Greenberg, S. Modular components of phagocytosis. J. Leukoc. Biol. 66, 712\u2013717 (1999).","journal-title":"J. Leukoc. Biol."},{"key":"1249_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0955-0674(97)80156-1","volume":"9","author":"N Tapon","year":"1997","unstructured":"Tapon, N. & Hall, A. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol. 9, 86\u201392 (1997).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1249_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01148","volume":"420","author":"S Etienne-Manneville","year":"2002","unstructured":"Etienne-Manneville, S. & Hall, A. Rho GTPases in cell biology. Nature 420, 629\u2013635 (2002).","journal-title":"Nature"},{"key":"1249_CR25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jnnp.54.5.388","volume":"54","author":"WR Gibb","year":"1991","unstructured":"Gibb, W. R. & Lees, A. J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 54, 388\u2013396 (1991).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1249_CR26","first-page":"1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier, P., Hirsch, E. C., Agid, Y. & Graybiel, A. M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain 122, 1437\u20131448 (1999).","journal-title":"II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain"},{"key":"1249_CR27","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/brain\/122.8.1421","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier, P., Hirsch, E. C., Agid, Y. & Graybiel, A. M. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 122, 1421\u20131436 (1999).","journal-title":"Brain"},{"key":"1249_CR28","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley, J. M. & Lees, A. J. Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain 114, 2283\u20132301 (1991).","journal-title":"Brain"},{"key":"1249_CR29","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath, T. et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat. Neurosci. 25, 588\u2013595 (2022).","journal-title":"Nat. Neurosci."},{"key":"1249_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.stem.2010.08.014","volume":"7","author":"A Sierra","year":"2010","unstructured":"Sierra, A. et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 7, 483\u2013495 (2010).","journal-title":"Cell Stem Cell"},{"key":"1249_CR31","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch, E. C. & Hunot, S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 8, 382\u2013397 (2009).","journal-title":"Lancet Neurol."},{"key":"1249_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-018-0592-3","volume":"6","author":"S Rakic","year":"2018","unstructured":"Rakic, S. et al. Systemic infection modifies the neuroinflammatory response in late stage Alzheimer\u2019s disease. Acta Neuropathol. Commun. 6, 88 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"1249_CR33","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/brain\/awad309","volume":"147","author":"IJ Hartnell","year":"2024","unstructured":"Hartnell, I. J. et al. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology. Brain 147, 590\u2013606 (2024).","journal-title":"Brain"},{"key":"1249_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbi.2021.07.017","volume":"97","author":"LJ De Picker","year":"2021","unstructured":"De Picker, L. J. et al. Immune environment of the brain in schizophrenia and during the psychotic episode: a human post-mortem study. Brain Behav. Immun. 97, 319\u2013327 (2021).","journal-title":"Brain Behav. Immun."},{"key":"1249_CR35","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/mds.29432","volume":"38","author":"GC Brown","year":"2023","unstructured":"Brown, G. C., Camacho, M. & Williams-Gray, C. H. The endotoxin hypothesis of Parkinson\u2019s Disease. Mov. Disord. 38, 1143\u20131155 (2023).","journal-title":"Mov. Disord."},{"key":"1249_CR36","doi-asserted-by":"publisher","first-page":"577874","DOI":"10.1016\/j.jneuroim.2022.577874","volume":"367","author":"P Heman-Bozadas","year":"2022","unstructured":"Heman-Bozadas, P. et al. Lesion-associated microglia and macrophages mediate corralling and react with massive phagocytosis for debris clearance and wound healing after LPS-induced dopaminergic depletion. J. Neuroimmunol. 367, 577874 (2022).","journal-title":"J. Neuroimmunol."},{"key":"1249_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","volume":"20","author":"S Bournazos","year":"2020","unstructured":"Bournazos, S., Gupta, A. & Ravetch, J. V. The role of IgG Fc receptors in antibody-dependent enhancement. Nat. Rev. Immunol. 20, 633\u2013643 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1249_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-196","volume":"9","author":"M Fricker","year":"2012","unstructured":"Fricker, M., Oliva-Martin, M. J. & Brown, G. C. Primary phagocytosis of viable neurons by microglia activated with LPS or Abeta is dependent on calreticulin\/LRP phagocytic signalling. J. Neuroinflammation 9, 196 (2012).","journal-title":"J. Neuroinflammation"},{"key":"1249_CR39","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","volume":"118","author":"WJ Streit","year":"2009","unstructured":"Streit, W. J., Braak, H., Xue, Q. S. & Bechmann, I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol. 118, 475\u2013485 (2009).","journal-title":"Acta Neuropathol."},{"key":"1249_CR40","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1523\/JNEUROSCI.3441-12.2013","volume":"33","author":"CL Cunningham","year":"2013","unstructured":"Cunningham, C. L., Martinez-Cerdeno, V. & Noctor, S. C. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J. Neurosci. 33, 4216\u20134233 (2013).","journal-title":"J. Neurosci."},{"key":"1249_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.neuron.2019.02.006","volume":"102","author":"JW VanRyzin","year":"2019","unstructured":"VanRyzin, J. W. et al. Microglial phagocytosis of newborn cells is induced by endocannabinoids and sculpts sex differences in juvenile rat social play. Neuron 102, 435\u2013449 e436 (2019).","journal-title":"Neuron"},{"key":"1249_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jneuroim.2013.05.001","volume":"261","author":"C Barcia","year":"2013","unstructured":"Barcia, C. et al. Persistent phagocytic characteristics of microglia in the substantia nigra of long-term Parkinsonian macaques. J. Neuroimmunol. 261, 60\u201366 (2013).","journal-title":"J. Neuroimmunol."},{"key":"1249_CR43","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrm2447","volume":"9","author":"JA Swanson","year":"2008","unstructured":"Swanson, J. A. Shaping cups into phagosomes and macropinosomes. Nat. Rev. Mol. Cell Biol. 9, 639\u2013649 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1249_CR44","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1126\/science.7652575","volume":"269","author":"MF Olson","year":"1995","unstructured":"Olson, M. F., Ashworth, A. & Hall, A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269, 1270\u20131272 (1995).","journal-title":"Science"},{"key":"1249_CR45","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1091\/mbc.e03-08-0609","volume":"15","author":"K Kurokawa","year":"2004","unstructured":"Kurokawa, K., Itoh, R. E., Yoshizaki, H., Nakamura, Y. O. & Matsuda, M. Coactivation of Rac1 and Cdc42 at lamellipodia and membrane ruffles induced by epidermal growth factor. Mol. Biol. Cell 15, 1003\u20131010 (2004).","journal-title":"Mol. Biol. Cell"},{"key":"1249_CR46","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S0960-9822(01)00506-1","volume":"11","author":"S Krugmann","year":"2001","unstructured":"Krugmann, S. et al. Cdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex. Curr. Biol. 11, 1645\u20131655 (2001).","journal-title":"Curr. Biol."},{"key":"1249_CR47","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.celrep.2019.05.010","volume":"27","author":"LP Bernier","year":"2019","unstructured":"Bernier, L. P. et al. Nanoscale surveillance of the brain by microglia via cAMP-regulated filopodia. Cell Rep. 27, 2895\u20132908 e2894 (2019).","journal-title":"Cell Rep."},{"key":"1249_CR48","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrneurol.2012.118","volume":"8","author":"YH Liu","year":"2012","unstructured":"Liu, Y. H., Giunta, B., Zhou, H. D., Tan, J. & Wang, Y. J. Immunotherapy for Alzheimer disease: the challenge of adverse effects. Nat. Rev. Neurol. 8, 465\u2013469 (2012).","journal-title":"Nat. Rev. Neurol."},{"key":"1249_CR49","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrneurol.2009.219","volume":"6","author":"CA Lemere","year":"2010","unstructured":"Lemere, C. A. & Masliah, E. Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Nat. Rev. Neurol. 6, 108\u2013119 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"1249_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04012-x","volume":"21","author":"B Xiao","year":"2023","unstructured":"Xiao, B. & Tan, E. K. Immunotherapy trials in Parkinson\u2019s disease: challenges. J. Transl. Med. 21, 178 (2023).","journal-title":"J. Transl. Med."},{"key":"1249_CR51","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","volume":"164","author":"S Duty","year":"2011","unstructured":"Duty, S. & Jenner, P. Animal models of Parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease. Br. J. Pharmacol. 164, 1357\u20131391 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"1249_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JPD-2011-11023","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith, G. E. & Rademacher, D. J. MPTP mouse models of Parkinson\u2019s disease: an update. J. Parkinsons Dis. 1, 19\u201333 (2011).","journal-title":"J. Parkinsons Dis."},{"key":"1249_CR53","unstructured":"Paxinos, G. & Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates (Academic Press, 2001)."},{"key":"1249_CR54","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-030-23173-6_9","volume":"67","author":"M Roig-Martinez","year":"2019","unstructured":"Roig-Martinez, M., Saavedra-Lopez, E., Casanova, P. V., Cribaro, G. P. & Barcia, C. The MTOC\/Golgi complex at the T-cell immunological synapse. Results Probl. Cell Differ. 67, 223\u2013231 (2019).","journal-title":"Results Probl. Cell Differ."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01249-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:04:12Z","timestamp":1770030252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01249-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1249"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01249-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.04.602092","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}